Minimal limb volume change has a significant impact on breast cancer survivors

Lymphology

Volumn 42, Issue 4, 2009, Pages 161-175

  Cormier, Janice N ^a   Xing, Y ^a   Zaniletti, I ^b   Askew, R L ^a   Stewart, B R ^b   Armer, J M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Breast cancer; Lymphedema; Quality of life; Symptom assessment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LIMB VOLUME CHANGE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MUSCULOSKELETAL SYSTEM PARAMETERS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; EXTREMITIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE; SURVIVORS;

EID: 77049093995     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Meek, AG: Breast radiotherapy and lymphedema. Cancer 83 (12 Suppl American) (1998), 2788-2797.
2. Rockson, SG: Precipitating factors in lymphedema: Myths and realities. Cancer 83 (12 Suppl American) (1998), 2814-2816.
3. Passik, SD, MV McDonald: Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 83 (12 Suppl American) (1998), 2817-2820.
4. Petrek, JA, MC Heelan: Incidence of breast carcinoma-related lymphedema. Cancer 83 (12 Suppl American) (1998), 2776-2781.
5. Hull, MM: Functional and psychosocial aspects of lymphedema in women treated for breast cancer. Innov. Breast Cancer Care 3 (1998), 117-118.
6. Geller, BM, PM Vacek, P O'Brien, et al: Factors associated with arm swelling after breast cancer surgery. J. Womens Health (Larchmt) 12 (2003), 921-930.
7. Armer, JM, BR Stewart: A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat. Res. Biol. 3 (2005), 208-217.
8. Tierney, S, M Aslam, K Rennie, et al: Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur. J. Vasc. Endovasc. Surg. 12 (1996), 412-417.
9. Mayrovitz, HN: Limb volume measurement in patients with edema: Comparisons between manual and automated methods. Symposium on Advanced World Care (Poster Presentation) April 1999.
10. Armer, JM, ME Radina, D Porock, et al: Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs. Res. 52 (2003), 370-379.
11. Armer, JM, D Porock: Self-management of fatigue among women with lymphedema. Lymphology 35(Suppl) (2002) 208-213.
12. Kwan, W, J Jackson, LM Weir, et al: Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life. J. Clin. Oncol. 20 (2002), 4242-4248.
13. Morrow, GR, J Lindke, P Black: Measurement of quality of life in patients: Psychometric analyses of the Functional Living Index-Cancer (FLIC). Qual. Life Res. 1 (1992), 287-296.
14. Schipper, H, J Clinch, A McMurray, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: development and validation. J. Clin. Oncol. 2 (1984), 472-483.
15. Ware, JE, Jr, M Kosinski, MS Bayliss, et al: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med. Care 33 (4 Suppl) (1995), AS264-279.
16. Ware, JE, Jr, CD Sherbourne: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992), 473-483.
17. Wilson, RW, LM Hutson, D Vanstry: Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Phys. Ther. 85 (2005), 851-860.
18. Hays, RD, CD Sherbourne, RM Mazel: The RAND 36-Item Health Survey 1.0. Health Econ. 2 (1993), 217-227.
19. Stout Gergich, NL, LA Pfalzer, C McGarvey, et al: Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112 (2008), 2809-2819.
20. Langer, I, U Guller, G Berclaz, et al: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann. Surg. 245 (2007), 452-461.
21. Wilke, LG, LM McCall, KE Posther, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann. Surg. Oncol. 13 (2006), 491-500.
22. Blanchard, DK, JH Donohue, C Reynolds, et al: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch. Surg. 138 (2003), 482-487; discussion 487-488.
23. Haid, A, T Kuehn, P Konstantiniuk, et al: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur. J. Surg. Oncol. 28 (2002), 705-710.
24. Sener, SF, DJ Winchester, CH Martz, et al: Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 (2001), 748-752.
25. Lucci, A, LM McCall, PD Beitsch, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin. Oncol. 25 (2007), 3657-3663.
26. Estimated new cancer cases and deaths by sex for all sites, US, 2007. In: Cancer Facts and Figures 2007 Graphs and Figures. Society, AC (Ed.), 2007.
27. Huntington, MO: Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56 (1985), 472-474.
28. Heasman, KZ, HJ Sutherland, JA Campbell, et al: Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res. Treat. 5 (1985), 195-200.
29. Camoriano, JK, CL Loprinzi, JN Ingle, et al: Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J. Clin. Oncol. 8 (1990), 1327-1334.
30. Goodwin, P, MJ Esplen, K Butler, et al: Multidisciplinary weight management in locoregional breast cancer: Results of a phase II study. Breast Cancer Res. Treat. 48 (1998), 53-64.
31. Denmark-Wahnefried, W, BL Peterson, EP Winer, et al: Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 19 (2001), 2381-2389.
32. Hoskin, PJ, S Ashley, JR Yarnold: Weight gain after primary surgery for breast cancer - effect of tamoxifen. Breast Cancer Res. Treat. 22 (1992), 129-132.
33. Calle, EE, C Rodriguez, K Walker-Thurmond, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003), 1625-1638.
34. Daling, JR, KE Malone, DR Doody, et al: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92 (2001), 720-729.
35. Rock, CL, W Demark-Wahnefried: Can lifestyle modification increase survival in women diagnosed with breast cancer? J. Nutr. 132(11 Suppl) (2002), 3504S-3507S.
36. Chlebowski, RT, E Aiello, A McTiernan: Weight loss in breast cancer patient management. J. Clin. Oncol. 20 (2002), 1128-1143.
37. Enger, SM, JM Greif, J Polikoff, et al: Body weight correlates with mortality in early-stage breast cancer. Arch Surg 139 (2004), 954-958; discussion 958-960.
38. Kroenke, CH, WY Chen, B Rosner, et al: Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 23 (2005), 1370-1378.
39. Maru, S, YT van der Schouw, CH Gimbrere, et al: Body mass index and short-term weight change in relation to mortality in Dutch women after age 50 y. Am. J. Clin. Nutr. 80 (2004), 231-236.
40. Fleissig, A, LJ Fallowfield, CI Langridge, et al: Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res. Treat. 95 (2006), 279-293.
41. Coster, S, K Poole, LJ Fallowfield: The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res. Treat. 68 (2001), 273-282.
42. Purushotham, AD, TM Bennett Britton, MB Klevesath, et al: Lymph node status and breast cancer-related lymphedema. Ann. Surg. 246 (2007), 42-45.
43. Soran, A, G D'Angelo, M Begovic, et al: Breast cancer-related lymphedema - what are the significant predictors and how they affect the severity of lymphedema? Breast J. 12 (2006), 536-543.
44. Mirolo, BR, IH Bunce, M Chapman, et al: Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nurs. 18 (1995), 197-205.
45. Velanovich, V, W Szymanski: Quality of life of breast cancer patients with lymphedema. Am. J. Surg. 177 (1999), 184-187; discussion 188.
46. Beaulac, SM, LA McNair, TE Scott, et al: Lymphedema and quality of life in survivors of early-stage breast cancer. Arch. Surg. 137 (2002), 1253-1237.
47. Williams, AF, A Vadgama, PJ Franks, et al: A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur. J. Cancer Care (Engl) 11 (2002), 254-261.
48. Cleeland, CS: Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. J. Natl. Cancer Inst. Monogr. 37 (2007), 16-21.